Selected research
Market Analysis & Forecast
Global Plasma Collection and Processing Market Analysis and Forecast 2026-2032
Market perspective
The global Plasma Collection and Processing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Plasma Collection and Processing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Plasma Collection and Processing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Plasma Collection and Processing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Plasma Collection and Processing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Plasma Collection and Processing include CSL Behring, Baxter, Grifols, Octapharma, Takeda, Octaphaarma, Kedrion, BPL and LFB Group, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Plasma Collection and Processing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Plasma Collection and Processing, also provides the revenue of main regions and countries. Of the upcoming market potential for Plasma Collection and Processing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Plasma Collection and Processing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Plasma Collection and Processing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Plasma Collection and Processing revenue, projected growth trends, production technology, application and end-user industry.
Plasma Collection and Processing Segment by Company
CSL Behring
Baxter
Grifols
Octapharma
Takeda
Octaphaarma
Kedrion
BPL
LFB Group
Tiantan Biological Products
Shanghai RAAS Blood Products
Hualan Biological
Pacific Shuanglin Bio-pharmacy
China Biologic Products
Plasma Collection and Processing Segment by Type
Single Plasma Collection Station
Other
Plasma Collection and Processing Segment by Application
Albumin
Immunoglobulin
Coagulation Factor
Plasma Collection and Processing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Collection and Processing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasma Collection and Processing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Collection and Processing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Plasma Collection and Processing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Plasma Collection and Processing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plasma Collection and Processing revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Single Plasma Collection Station
- Other
Applications
- Albumin
- Immunoglobulin
- Coagulation Factor
Companies covered
- CSL Behring
- Baxter
- Grifols
- Octapharma
- Takeda
- Octaphaarma
- Kedrion
- BPL
- LFB Group
- Tiantan Biological Products
- Shanghai RAAS Blood Products
- Hualan Biological
- Pacific Shuanglin Bio-pharmacy
- China Biologic Products
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Plasma Collection and Processing Market by Type
- 1.2.1 Global Plasma Collection and Processing Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Single Plasma Collection Station
- 1.2.3 Other
- 1.3 Plasma Collection and Processing Market by Application
- 1.3.1 Global Plasma Collection and Processing Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Albumin
- 1.3.3 Immunoglobulin
- 1.3.4 Coagulation Factor
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Plasma Collection and Processing Market Dynamics
- 2.1 Plasma Collection and Processing Industry Trends
- 2.2 Plasma Collection and Processing Industry Drivers
- 2.3 Plasma Collection and Processing Industry Opportunities and Challenges
- 2.4 Plasma Collection and Processing Industry Restraints
3 Global Growth Perspective
- 3.1 Global Plasma Collection and Processing Market Perspective (2021-2032)
- 3.2 Global Plasma Collection and Processing Growth Trends by Region
- 3.2.1 Global Plasma Collection and Processing Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Plasma Collection and Processing Market Size by Region (2021-2026)
- 3.2.3 Global Plasma Collection and Processing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Plasma Collection and Processing Revenue by Players
- 4.1.1 Global Plasma Collection and Processing Revenue by Players (2021-2026)
- 4.1.2 Global Plasma Collection and Processing Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Plasma Collection and Processing Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Plasma Collection and Processing Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Plasma Collection and Processing Key Players Headquarters & Area Served
- 4.4 Global Plasma Collection and Processing Players, Product Type & Application
- 4.5 Global Plasma Collection and Processing Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Plasma Collection and Processing Market CR5 and HHI
- 4.6.3 2025 Plasma Collection and Processing Tier 1, Tier 2, and Tier 3
5 Plasma Collection and Processing Market Size by Type
- 5.1 Global Plasma Collection and Processing Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Plasma Collection and Processing Revenue by Type (2021-2032)
- 5.3 Global Plasma Collection and Processing Revenue Market Share by Type (2021-2032)
6 Plasma Collection and Processing Market Size by Application
- 6.1 Global Plasma Collection and Processing Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Plasma Collection and Processing Revenue by Application (2021-2032)
- 6.3 Global Plasma Collection and Processing Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 CSL Behring
- 7.1.1 CSL Behring Company Information
- 7.1.2 CSL Behring Business Overview
- 7.1.3 CSL Behring Plasma Collection and Processing Revenue and Gross Margin (2021-2026)
- 7.1.4 CSL Behring Plasma Collection and Processing Product Portfolio
- 7.1.5 CSL Behring Recent Developments
- 7.2 Baxter
- 7.2.1 Baxter Company Information
- 7.2.2 Baxter Business Overview
- 7.2.3 Baxter Plasma Collection and Processing Revenue and Gross Margin (2021-2026)
- 7.2.4 Baxter Plasma Collection and Processing Product Portfolio
- 7.2.5 Baxter Recent Developments
- 7.3 Grifols
- 7.3.1 Grifols Company Information
- 7.3.2 Grifols Business Overview
- 7.3.3 Grifols Plasma Collection and Processing Revenue and Gross Margin (2021-2026)
- 7.3.4 Grifols Plasma Collection and Processing Product Portfolio
- 7.3.5 Grifols Recent Developments
- 7.4 Octapharma
- 7.4.1 Octapharma Company Information
- 7.4.2 Octapharma Business Overview
- 7.4.3 Octapharma Plasma Collection and Processing Revenue and Gross Margin (2021-2026)
- 7.4.4 Octapharma Plasma Collection and Processing Product Portfolio
- 7.4.5 Octapharma Recent Developments
- 7.5 Takeda
- 7.5.1 Takeda Company Information
- 7.5.2 Takeda Business Overview
- 7.5.3 Takeda Plasma Collection and Processing Revenue and Gross Margin (2021-2026)
- 7.5.4 Takeda Plasma Collection and Processing Product Portfolio
- 7.5.5 Takeda Recent Developments
- 7.6 Octaphaarma
- 7.6.1 Octaphaarma Company Information
- 7.6.2 Octaphaarma Business Overview
- 7.6.3 Octaphaarma Plasma Collection and Processing Revenue and Gross Margin (2021-2026)
- 7.6.4 Octaphaarma Plasma Collection and Processing Product Portfolio
- 7.6.5 Octaphaarma Recent Developments
- 7.7 Kedrion
- 7.7.1 Kedrion Company Information
- 7.7.2 Kedrion Business Overview
- 7.7.3 Kedrion Plasma Collection and Processing Revenue and Gross Margin (2021-2026)
- 7.7.4 Kedrion Plasma Collection and Processing Product Portfolio
- 7.7.5 Kedrion Recent Developments
- 7.8 BPL
- 7.8.1 BPL Company Information
- 7.8.2 BPL Business Overview
- 7.8.3 BPL Plasma Collection and Processing Revenue and Gross Margin (2021-2026)
- 7.8.4 BPL Plasma Collection and Processing Product Portfolio
- 7.8.5 BPL Recent Developments
- 7.9 LFB Group
- 7.9.1 LFB Group Company Information
- 7.9.2 LFB Group Business Overview
- 7.9.3 LFB Group Plasma Collection and Processing Revenue and Gross Margin (2021-2026)
- 7.9.4 LFB Group Plasma Collection and Processing Product Portfolio
- 7.9.5 LFB Group Recent Developments
- 7.10 Tiantan Biological Products
- 7.10.1 Tiantan Biological Products Company Information
- 7.10.2 Tiantan Biological Products Business Overview
- 7.10.3 Tiantan Biological Products Plasma Collection and Processing Revenue and Gross Margin (2021-2026)
- 7.10.4 Tiantan Biological Products Plasma Collection and Processing Product Portfolio
- 7.10.5 Tiantan Biological Products Recent Developments
- 7.11 Shanghai RAAS Blood Products
- 7.11.1 Shanghai RAAS Blood Products Company Information
- 7.11.2 Shanghai RAAS Blood Products Business Overview
- 7.11.3 Shanghai RAAS Blood Products Plasma Collection and Processing Revenue and Gross Margin (2021-2026)
- 7.11.4 Shanghai RAAS Blood Products Plasma Collection and Processing Product Portfolio
- 7.11.5 Shanghai RAAS Blood Products Recent Developments
- 7.12 Hualan Biological
- 7.12.1 Hualan Biological Company Information
- 7.12.2 Hualan Biological Business Overview
- 7.12.3 Hualan Biological Plasma Collection and Processing Revenue and Gross Margin (2021-2026)
- 7.12.4 Hualan Biological Plasma Collection and Processing Product Portfolio
- 7.12.5 Hualan Biological Recent Developments
- 7.13 Pacific Shuanglin Bio-pharmacy
- 7.13.1 Pacific Shuanglin Bio-pharmacy Company Information
- 7.13.2 Pacific Shuanglin Bio-pharmacy Business Overview
- 7.13.3 Pacific Shuanglin Bio-pharmacy Plasma Collection and Processing Revenue and Gross Margin (2021-2026)
- 7.13.4 Pacific Shuanglin Bio-pharmacy Plasma Collection and Processing Product Portfolio
- 7.13.5 Pacific Shuanglin Bio-pharmacy Recent Developments
- 7.14 China Biologic Products
- 7.14.1 China Biologic Products Company Information
- 7.14.2 China Biologic Products Business Overview
- 7.14.3 China Biologic Products Plasma Collection and Processing Revenue and Gross Margin (2021-2026)
- 7.14.4 China Biologic Products Plasma Collection and Processing Product Portfolio
- 7.14.5 China Biologic Products Recent Developments
8 North America
- 8.1 North America Plasma Collection and Processing Revenue (2021-2032)
- 8.2 North America Plasma Collection and Processing Revenue by Type (2021-2032)
- 8.2.1 North America Plasma Collection and Processing Revenue by Type (2021-2026)
- 8.2.2 North America Plasma Collection and Processing Revenue by Type (2027-2032)
- 8.3 North America Plasma Collection and Processing Revenue Share by Type (2021-2032)
- 8.4 North America Plasma Collection and Processing Revenue by Application (2021-2032)
- 8.4.1 North America Plasma Collection and Processing Revenue by Application (2021-2026)
- 8.4.2 North America Plasma Collection and Processing Revenue by Application (2027-2032)
- 8.5 North America Plasma Collection and Processing Revenue Share by Application (2021-2032)
- 8.6 North America Plasma Collection and Processing Revenue by Country
- 8.6.1 North America Plasma Collection and Processing Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Plasma Collection and Processing Revenue by Country (2021-2026)
- 8.6.3 North America Plasma Collection and Processing Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Plasma Collection and Processing Revenue (2021-2032)
- 9.2 Europe Plasma Collection and Processing Revenue by Type (2021-2032)
- 9.2.1 Europe Plasma Collection and Processing Revenue by Type (2021-2026)
- 9.2.2 Europe Plasma Collection and Processing Revenue by Type (2027-2032)
- 9.3 Europe Plasma Collection and Processing Revenue Share by Type (2021-2032)
- 9.4 Europe Plasma Collection and Processing Revenue by Application (2021-2032)
- 9.4.1 Europe Plasma Collection and Processing Revenue by Application (2021-2026)
- 9.4.2 Europe Plasma Collection and Processing Revenue by Application (2027-2032)
- 9.5 Europe Plasma Collection and Processing Revenue Share by Application (2021-2032)
- 9.6 Europe Plasma Collection and Processing Revenue by Country
- 9.6.1 Europe Plasma Collection and Processing Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Plasma Collection and Processing Revenue by Country (2021-2026)
- 9.6.3 Europe Plasma Collection and Processing Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Plasma Collection and Processing Revenue (2021-2032)
- 10.2 China Plasma Collection and Processing Revenue by Type (2021-2032)
- 10.2.1 China Plasma Collection and Processing Revenue by Type (2021-2026)
- 10.2.2 China Plasma Collection and Processing Revenue by Type (2027-2032)
- 10.3 China Plasma Collection and Processing Revenue Share by Type (2021-2032)
- 10.4 China Plasma Collection and Processing Revenue by Application (2021-2032)
- 10.4.1 China Plasma Collection and Processing Revenue by Application (2021-2026)
- 10.4.2 China Plasma Collection and Processing Revenue by Application (2027-2032)
- 10.5 China Plasma Collection and Processing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Plasma Collection and Processing Revenue (2021-2032)
- 11.2 Asia Plasma Collection and Processing Revenue by Type (2021-2032)
- 11.2.1 Asia Plasma Collection and Processing Revenue by Type (2021-2026)
- 11.2.2 Asia Plasma Collection and Processing Revenue by Type (2027-2032)
- 11.3 Asia Plasma Collection and Processing Revenue Share by Type (2021-2032)
- 11.4 Asia Plasma Collection and Processing Revenue by Application (2021-2032)
- 11.4.1 Asia Plasma Collection and Processing Revenue by Application (2021-2026)
- 11.4.2 Asia Plasma Collection and Processing Revenue by Application (2027-2032)
- 11.5 Asia Plasma Collection and Processing Revenue Share by Application (2021-2032)
- 11.6 Asia Plasma Collection and Processing Revenue by Country
- 11.6.1 Asia Plasma Collection and Processing Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Plasma Collection and Processing Revenue by Country (2021-2026)
- 11.6.3 Asia Plasma Collection and Processing Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Plasma Collection and Processing Revenue (2021-2032)
- 12.2 SAMEA Plasma Collection and Processing Revenue by Type (2021-2032)
- 12.2.1 SAMEA Plasma Collection and Processing Revenue by Type (2021-2026)
- 12.2.2 SAMEA Plasma Collection and Processing Revenue by Type (2027-2032)
- 12.3 SAMEA Plasma Collection and Processing Revenue Share by Type (2021-2032)
- 12.4 SAMEA Plasma Collection and Processing Revenue by Application (2021-2032)
- 12.4.1 SAMEA Plasma Collection and Processing Revenue by Application (2021-2026)
- 12.4.2 SAMEA Plasma Collection and Processing Revenue by Application (2027-2032)
- 12.5 SAMEA Plasma Collection and Processing Revenue Share by Application (2021-2032)
- 12.6 SAMEA Plasma Collection and Processing Revenue by Country
- 12.6.1 SAMEA Plasma Collection and Processing Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Plasma Collection and Processing Revenue by Country (2021-2026)
- 12.6.3 SAMEA Plasma Collection and Processing Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst